Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    7508092 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
Conditions: Pain/Cancer;   Pain, Intractable
Interventions: Drug: (Resiniferatoxin)(RTX);   Drug: Intrathecal Resiniferatoxin
2 Recruiting Real-time Cancer Pain Assessment and Intervention
Conditions: Malignancy;   Pain
Interventions: Procedure: real-time monitoring and instruction of cancer pain;   Procedure: standard cancer pain care

Study has passed its completion date and status has not been verified in more than two years.